NSTG - NanoString Technologies, Inc.
| Previous Close | 16.91 |
| Open | 16.94 |
| Bid | 16.71 x 800 |
| Ask | 16.75 x 1300 |
| Day's Range | 16.70 - 17.00 |
| 52 Week Range | 5.87 - 18.86 |
| Volume | 56,454 |
| Avg. Volume | 314,440 |
| Market Cap | 514.157M |
| Beta (3Y Monthly) | 1.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.45 |
| Earnings Date | Oct 31, 2018 - Nov 5, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.67 |
- Thomson Reuters StreetEvents•5 days ago
Edited Transcript of NSTG earnings conference call or presentation 8-Nov-18 9:30pm GMT
Q3 2018 NanoString Technologies Inc Earnings Call
- Zacks•11 days ago
NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates
NanoString (NSTG) delivered earnings and revenue surprises of 6.67% and 10.49%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•11 days ago
NanoString: 3Q Earnings Snapshot
SEATTLE (AP) _ NanoString Technologies Inc. (NSTG) on Thursday reported a loss of $16.5 million in its third quarter. The Seattle-based company said it had a loss of 56 cents per share. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.
- GlobeNewswire•11 days ago
NanoString Technologies Releases Operating Results for Third Quarter of 2018
SEATTLE, Nov. 08, 2018 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today.
- GlobeNewswire•11 days ago
NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing
NanoString Technologies, Inc. (NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for the molecular characterization of CAR-T cells in research, development and manufacturing. The nCounter® CAR-T Characterization Panel was created in collaboration with eight leading centers in the field of CAR-T therapy. This novel panel is designed for use across the entirety of the CAR-T work flow including leukapheresis, manufacturing and post-infusion monitoring and may further efforts for product optimization, development of quality controls and an understanding of mechanisms that influence CAR-T performance.
- GlobeNewswire•12 days ago
NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Includes Data from More than Twenty-Five Studies, Including Six Using GeoMx Digital Spatial Profiler SEATTLE, Nov. 07, 2018 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a.
- GlobeNewswire•14 days ago
NanoString to Present at the 2018 Canaccord Medical Technologies and Diagnostics Forum
SEATTLE, Nov. 05, 2018 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today.
- GlobeNewswire•20 days ago
NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference
Demonstrates Potential of Hyb & Seq NGS Platform for Infectious Disease Applications SEATTLE, Oct. 30, 2018 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of.
- GlobeNewswire•21 days ago
MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology
NanoString Technologies, Inc. (NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics (MGNX) and NanoString have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program. Disrupting these non-redundant inhibitory pathways may further restore exhausted T-cell function and enhance anti-tumor efficacy. MacroGenics and NanoString will conduct joint research using the PanCancer IO 360™ Panel to explore potentially predictive signatures for MGD013 clinical applications.
- GlobeNewswire•25 days ago
Recent Analysis Shows PennyMac Mortgage Investment Trust, Amicus Therapeutics, Children's Place, PLDT, NanoString Technologies, and Worthington Industries Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Oct. 25, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- GlobeNewswire•last month
NanoString Announces $100 Million Term Loan Facility with CRG
The proceeds of the initial draw under the CRG term loan facility, made in the aggregate principal amount of $60 million, will be used to refinance NanoString’s existing CRG term loan facility, under which approximately $50 million is currently outstanding, for working capital and general corporate purposes and for transaction-related fees and expenses. “This financing illustrates the confidence of our existing capital partners at CRG in the health and growth trajectory of our core nCounter® franchise, as well as in the anticipated launch of our GeoMx™ Digital Spatial Profiling platform,” said Thomas Bailey, CFO of NanoString Technologies.
- Zacks•last month
Is the Options Market Predicting a Spike in NanoString Technologies (NSTG) Stock?
Investors need to pay close attention to NanoString Technologies (NSTG) stock based on the movements in the options market lately.
- GlobeNewswire•last month
Landmark Publications in Nature Medicine use NanoString’s Digital Spatial Profiling Platform to Discover Novel Insights in Immuno-Oncology
The GeoMx Digital Spatial Profiler was used to characterize pretreatment tumor biopsies and revealed differential expression of several potential biomarkers, including B2M and CD3. The first publication was led by researchers at the DSP Center of Excellence at the Netherland Cancer Institute and entitled “Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma” (https://www.nature.com/articles/s41591-018-0198-0). “We used the DSP platform to characterize pretreatment tumor biopsies to understand how the preexisting immune status of the melanoma biopsies predicts response,” said Christian Blank, M.D., Group Leader of Immunology at the Netherlands Cancer Institute.
- GlobeNewswire•last month
NanoString to Release Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 8, 2018
SEATTLE, Oct. 08, 2018 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today.
- GlobeNewswire•2 months ago
NanoString Announces the University of Oxford Selected as the Winning Recipient in GeoMx Digital Spatial Profiler Grant Program
NanoString Technologies, Inc. (NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the University of Oxford has been selected as the winning recipient of a grant for a GeoMx™ Digital Spatial Profiler (DSP) as part of the DSP grant program. The grant program included more than 100 submissions from around the world. “We are honored to announce that Dr. Fadi Issa from University of Oxford has been selected as the winning recipient of a grant for our GeoMx Digital Spatial Profiler,” said Chad Brown, senior vice president of sales and marketing of NanoString Technologies.
- GlobeNewswire•2 months ago
Consolidated Research: 2018 Summary Expectations for PLDT, Fidus Investment, NanoString Technologies, Maximus, Prologis, and SailPoint Technologies — Fundamental Analysis, Key Performance Indications
NEW YORK, Sept. 25, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Market Realist•2 months agoWhy Is Pacific Biosciences Stock Up ~6.2% Today?
Today, Pacific Biosciences of California (PACB) is trading at $5.16 per share, up ~6.17% from yesterday’s close of $4.86. On September 12, Pacific Biosciences stock closed at $4.86, a 6.46% increase from its September 11 closing price of $4.57. Its September 12 stock price represented an ~141.0% rise from its 52-week low of $2.02 on April 2. Its stock price hit its 52-week high of $5.58 on October 3, 2017.
- GlobeNewswire•2 months ago
NanoString to Present at the Morgan Stanley Global Healthcare Conference
SEATTLE, Sept. 10, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’ s management is ...
- GlobeNewswire•2 months ago
NanoString Launches Priority Site Program for New GeoMx Digital Spatial Profiler
The GeoMx Digital Spatial Profiler (DSP) enables researchers to rapidly and quantitatively characterize tissue morphology with a high-throughput, high-plex RNA and protein profiling system that preserves precious samples for future analyses. The GPS Program provides customers the opportunity to be among the first to receive a GeoMx instrument following its expected commercial launch in the first half of 2019, as well as advanced service and support. Inclusion in the GPS Program will also provide researchers, the opportunity to begin generating data on their samples through the Technology Access Program in advance of receiving their GeoMx instrument. GPS status will be limited to the first 20 participants who purchase the commercial system. “The potential for the GeoMx system to enable a new field of spatial genomics is tremendously exciting,” said Chad Brown, senior vice president of sales & marketing at NanoString.
- GlobeNewswire•3 months ago
NanoString to Present at the Baird 2018 Global Healthcare Conference
SEATTLE, Aug. 22, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’ s management is ...
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of NSTG earnings conference call or presentation 7-Aug-18 8:30pm GMT
Q2 2018 NanoString Technologies Inc Earnings Call
- Zacks•3 months ago
NanoString Technologies (NSTG) Reports Q2 Loss, Misses Revenue Estimates
NanoString (NSTG) delivered earnings and revenue surprises of -12.68% and -0.42%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•3 months ago
NanoString: 2Q Earnings Snapshot
SEATTLE (AP) _ NanoString Technologies Inc. (NSTG) on Tuesday reported a loss of $20.6 million in its second quarter. On a per-share basis, the Seattle-based company said it had a loss of 80 cents. The results fell short of Wall Street expectations.
